Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- CYH -19.6%, SAVE -15.6%, ESND -13.9%, CMPR -10.4%, TWTR -9.6%,FFIV -9.4%, ETH -9.1%, BWLD -8.6%, RCII -6.5%, TER -5.7%, BMY -5.3%,MB -5.2%, ATTU -4.3%, WHR -4.2%, WLL -4%, FTNT -3.9%, ADP -3.9%,QEP -3.5%, (also discloses entry into a definitive agreement to acquire crude oil and natural gas properties in the Permian Basin for an aggregate purchase price of $732 mln), ASGN -3.3%, JCI -3%, NMM -3%,DB -2.4%, SU -2.2%, CDE -2%, ESV -1.7%, UBSI -1.6%, KEX -1.5%, PSA-1.4%, LUV -1.4%, LYG -1.4%, PF -1.3%, SB -1.2%, WPG -1.2%, VIVO-1%, DOW -0.7%, TZOO -0.5%, .
M&A news:
- TBK -4.5% (to acquire Valley Bancorp; commences common stock offering)
Other news:
- IPCI -40% (provides update on FDA Advisory Committees Meeting for Rexista)
- CUR -16.2% (commences underwritten offering to issue and sell shares of its common stock and warrants to purchase shares of its common stock)
- AZN -15.3% (reports initial results from the ongoing MYSTIC trial in Stage IV lung cancer; trial did not meet a primary endpointalso reported earnings)
- TTPH -3.6% (commences offering of $60 mln of shares of its common stock; all of the shares of common stock)
- THC -3.5% (following CYH guidance)
Analyst comments:
- X -0.8% (downgraded to Neutral from Buy at Longbow)